{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:41:39Z","timestamp":1790163699652,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["19mk0101085"],"award-info":[{"award-number":["19mk0101085"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["22mk0101173j"],"award-info":[{"award-number":["22mk0101173j"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.resinv.2025.04.015","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T19:01:53Z","timestamp":1745607713000},"page":"524-531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical characteristics of drug-induced interstitial pneumonia in Japan"],"prefix":"10.1016","volume":"63","author":[{"given":"Miwa","family":"Yamanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8158-6100","authenticated-orcid":false,"given":"Atsuhito","family":"Ushiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9484-7912","authenticated-orcid":false,"given":"Koichiro","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Gemma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8949-1293","authenticated-orcid":false,"given":"Yoichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6669-8152","authenticated-orcid":false,"given":"Yoshiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8584-8515","authenticated-orcid":false,"given":"Masayuki","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2025.04.015_bib1","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1164\/rccm.200710-1501OC","article-title":"Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study","volume":"177","author":"Kudoh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.04.015_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(03)12190-3","article-title":"Severe acute interstitial pneumonia and gefitinib","volume":"361","author":"Inoue","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2025.04.015_bib3","first-page":"405","article-title":"High prevalence of drug-induced pneumonia in Japan","volume":"50","author":"Azuma","year":"2007","journal-title":"Jpn Med Assoc J"},{"key":"10.1016\/j.resinv.2025.04.015_bib4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/pds.1071","article-title":"National differences in reporting \u2018pneumonia\u2019 and \u2018pneumonia interstitial\u2019: an analysis of the WHO International Drug Monitoring Database on 15 drugs in nine countries for seven pulmonary conditions","volume":"14","author":"Koo","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.resinv.2025.04.015_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/pds.3998","article-title":"Geographical variation in reporting interstitial Lung Disease as an adverse drug reaction: findings from an European Medicines Agency analysis of reports in EudraVigilance","volume":"25","author":"Pinheiro","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.resinv.2025.04.015_bib6","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1158\/1078-0432.CCR-03-0564","article-title":"United States food and drug administration drug approval summary: gefitinib (ZD1839; iressa) tablets","volume":"10","author":"Cohen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.resinv.2025.04.015_bib7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/s41397-020-0172-3","article-title":"Association of HLA-DRB1\u221704:05 allele with drug-induced interstitial lung disease in Japanese population","volume":"20","author":"Imatoh","year":"2020","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.resinv.2025.04.015_bib8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/jcm7100356","article-title":"Drug-induced interstitial lung disease: a systematic review","volume":"7","author":"Skeoch","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.resinv.2025.04.015_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100404","article-title":"Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment","volume":"7","author":"Conte","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.resinv.2025.04.015_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02776-2021","article-title":"Drug-induced interstitial lung disease","volume":"60","author":"Spagnolo","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2025.04.015_bib11","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s40264-020-00968-7","article-title":"Interstitial lung disease as an adverse drug reaction in Japan: exploration of regulatory actions as a basis for high reporting","volume":"43","author":"Iwasa","year":"2020","journal-title":"Drug Saf"},{"key":"10.1016\/j.resinv.2025.04.015_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/2050312120918264","article-title":"Analysis of drug-induced interstitial lung disease using the Japanese Adverse Drug Event Report database","volume":"8","author":"Matsumoto","year":"2020","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.resinv.2025.04.015_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1465-9921-14-133","article-title":"Serum heat shock protein 47 levels in patients with drug-induced lung disease","volume":"14","author":"Kakugawa","year":"2013","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2025.04.015_bib14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1634\/theoncologist.2012-0248","article-title":"High-resolution computed tomography findings for patients with drug-induced pulmonary toxicity, with special reference to hypersensitivity pneumonitis-like patterns in gemcitabine-induced cases","volume":"18","author":"Tamura","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.resinv.2025.04.015_bib15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/thorax.58.10.872","article-title":"Circulating KL-6 levels in patients with drug induced pneumonitis","volume":"58","author":"Ohnishi","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2025.04.015_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s11547-010-0608-y","article-title":"Prospective evaluation of drug-induced lung toxicity with high-resolution CT and transbronchial biopsy","volume":"116","author":"Piciucchi","year":"2011","journal-title":"Radiol Med"},{"key":"10.1016\/j.resinv.2025.04.015_bib17","first-page":"36","article-title":"The role of transbronchial lung biopsy for the diagnosis of diffuse drug-induced lung disease: a case series of 44 patients","volume":"25","author":"Romagnoli","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.resinv.2025.04.015_bib18","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1148\/radiol.2243011236","article-title":"Drug-induced pneumonitis: thin-section CT findings in 60 patients","volume":"224","author":"Akira","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2025.04.015_bib19","first-page":"1556","article-title":"A case of pneumonitis due to sho-saiko-to","volume":"27","author":"Tsukiyama","year":"1989","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"10.1016\/j.resinv.2025.04.015_bib20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.resinv.2016.11.007","article-title":"Japanese herbal medicine-induced pneumonitis: a review of 73 patients","volume":"55","author":"Enomoto","year":"2017","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2025.04.015_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.lungcan.2013.11.016","article-title":"Risk of interstitial lung disease with gefitinib and erlotinib in advanced non-small cell lung cancer: a systematic review and meta-analysis of clinical trials","volume":"83","author":"Shi","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2025.04.015_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chest.2017.04.177","article-title":"Incidence of pneumonitis with use of programmed death 1 and programmed death-ligand 1 inhibitors in non-small cell lung cancer: a systematic review and meta-analysis of trials","volume":"152","author":"Khunger","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2025.04.015_bib23","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/cas.12550","article-title":"Final safety and efficacy of erlotinib in the phase 4 POLARSTAR surveillance study of 10 708 Japanese patients with non-small-cell lung cancer","volume":"105","author":"Gemma","year":"2014","journal-title":"Cancer Sci"},{"key":"10.1016\/j.resinv.2025.04.015_bib24","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/cncr.35349","article-title":"The safety of trastuzumab deruxtecan (DS-8201) with a focus on interstitial lung disease and\/or pneumonitis: a systematic review and single-arm meta-analysis","volume":"130","author":"Li","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.resinv.2025.04.015_bib25","article-title":"Immune checkpoint inhibitor-associated pneumonitis in non-small cell lung cancer: current understanding in characteristics, diagnosis, and management","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2025.04.015_bib26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13256-017-1333-0","article-title":"Methotrexate-induced Hypersensitivity Pneumonitis appearing after 30 years of use: a case report","volume":"11","author":"Salehi","year":"2017","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.resinv.2025.04.015_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/rheumatology\/keg466","article-title":"Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis","volume":"43","author":"Saravanan","year":"2004","journal-title":"Rheumatol (Oxf Engl)"},{"key":"10.1016\/j.resinv.2025.04.015_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028466","article-title":"Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts","volume":"9","author":"Kiely","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.resinv.2025.04.015_bib29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2125.2008.03177.x","article-title":"Amiodarone-induced pulmonary toxicity","volume":"66","author":"Ernawati","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.resinv.2025.04.015_bib30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/bmj.314.7081.619","article-title":"Amiodarone pulmonary toxicity","volume":"314","author":"Jessurun","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.resinv.2025.04.015_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0272-5231(03)00144-8","article-title":"Amiodarone pulmonary toxicity","volume":"25","author":"Camus","year":"2004","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.resinv.2025.04.015_bib32","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semarthrit.2010.11.002","article-title":"Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases","volume":"41","author":"Perez-Alvarez","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.resinv.2025.04.015_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/RHU.0b013e3181df8361","article-title":"Adalimumab-induced acute pneumonitis in a patient with rheumatoid arthritis","volume":"16","author":"Dascalu","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.015_bib34","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.3748\/wjg.v21.i7.2260","article-title":"Adalimumab-induced interstitial pneumonia in a patient with Crohn's disease","volume":"21","author":"Casanova","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.resinv.2025.04.015_bib35","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3109\/s10165-010-0308-4","article-title":"A case of adalimumab-associated interstitial pneumonia with rheumatoid arthritis","volume":"20","author":"Yamazaki","year":"2010","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.015_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/art.21716","article-title":"Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab","volume":"55","author":"Schoe","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2025.04.015_bib37","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/rheumatology\/kel220","article-title":"Adalimumab-associated pulmonary fibrosis","volume":"45","author":"Huggett","year":"2006","journal-title":"Rheumatol (Oxf Engl)."},{"key":"10.1016\/j.resinv.2025.04.015_bib38","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2169\/internalmedicine.50.4748","article-title":"Adalimumab-induced interstitial pneumonia with an improvement of pre-existing rheumatoid arthritis-associated lung involvement","volume":"50","author":"Komiya","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2025.04.015_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-224375","article-title":"Case of drug-induced interstitial lung disease secondary to adalimumab","volume":"2018","author":"Alaee","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.resinv.2025.04.015_bib40","first-page":"114","article-title":"A case of adalimumab-induced lung injury that developed 3 years after administration","volume":"7","author":"Koyauchi","year":"2018","journal-title":"AJRS"},{"key":"10.1016\/j.resinv.2025.04.015_bib41","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.abd.2020.08.016","article-title":"Interstitial lung disease due to anti-TNF use in the treatment of psoriasis","volume":"96","author":"Tur\u00edbio","year":"2021","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.resinv.2025.04.015_bib42","first-page":"479","article-title":"Lymphocyte transformation test for medicinal herbs yields false-positive results for first-visit patients","volume":"10","author":"Mantani","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.resinv.2025.04.015_bib43","first-page":"170","article-title":"Low specificity of the lymphocyte stimulation test for methotrexate in the patients with rheumatoid arthritis","volume":"19","author":"Hagiwara","year":"2007","journal-title":"Clin Rheumatol"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525000577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525000577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T23:50:17Z","timestamp":1749599417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534525000577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2212534525000577"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2025.04.015","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics of drug-induced interstitial pneumonia in Japan","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2025.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of The Japanese Respiratory Society.","name":"copyright","label":"Copyright"}]}}